Myriad Genetics, Inc.MYGNNASDAQ
Loading
Gross Profit Over TimeStable
Percentile Rank57
3Y CAGR+6.6%
5Y CAGR+8.8%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+6.6%/yr
vs -7.5%/yr prior
5Y CAGR
+8.8%/yr
Consistent
Acceleration
+14.0pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$576.60M-1.5%
2024$585.40M+13.2%
2023$517.00M+8.5%
2022$476.40M-3.4%
2021$493.00M+30.1%
2020$378.80M-16.3%
2019$452.50M-30.4%
2018$650.10M+9.2%
2017$595.40M-0.8%
2016$600.20M-